Oct 06, 9:10 AMPacBio announces TychoBio collaboration to provide HiFi and Kinnex sequencing for over 10,000 rare disease RNA samples

Peers: ILMN BIO BRKR TWST A QGEN WAT MTD DHR TMO

| Held by: ARKE ARKK ARKG IWM VTI IWO IBB VXF SCHA PRFZ

Index	RUT
Market Cap	813.85M
Enterprise Value	1.28B
Income	-131.39M
Sales	159.27M
Book/sh	-0.11
Cash/sh	0.76
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	485
IPO	Oct 27, 2010

P/E	-
Forward P/E	-
PEG	-
P/S	5.11
P/B	-
P/C	3.44
P/FCF	-
EV/EBITDA	-
EV/Sales	8.06
Quick Ratio	4.03
Current Ratio	4.92
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.43
EPS next Y	-0.46
EPS next Q	-0.13
EPS this Y	74.65%
EPS next Y	0.23%
EPS next 5Y	41.49%
EPS past 3/5Y	-9.18% -
Sales past 3/5Y	7.64% 15.19%
EPS Y/Y TTM	75.85%
Sales Y/Y TTM	2.02%
EPS Q/Q	-3.08%
Sales Q/Q	-1.91%
Earnings	Aug 05 AMC
EPS/Sales Surpr.	0.00% -2.31%

Insider Own	8.27%
Insider Trans	-0.10%
Inst Own	53.93%
Inst Trans	0.43%
ROA	-16.66%
ROE	-929.32%
ROIC	-19.56%
Gross Margin	34.29%
Oper. Margin	-101.67%
Profit Margin	-82.49%
SMA20	45.71%
SMA50	74.20%
SMA200	65.06%
Trades

Shs Outstand	310.81M
Shs Float	285.14M
Short Float	17.15%
Short Ratio	5.01
Short Interest	48.89M
52W High	3.43 -23.78%
52W Low	1.07 144.70%
Volatility	21.89% 10.72%
ATR (14)	0.24
RSI (14)	75.80
Beta	2.25
Rel Volume	0.25
Avg Volume	9.76M
Volume	123,605

Perf Week	10.48%
Perf Month	98.36%
Perf Quarter	62.63%
Perf Half Y	78.12%
Perf YTD	40.02%
Perf Year	87.02%
Perf 3Y	-67.79%
Perf 5Y	-89.76%
Perf 10Y	-70.48%
Recom	2.25
Target Price	2.16
Prev Close	2.70
Price	2.62
Change %	-3.03%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-26	Resumed	UBS	Neutral	$1.35
Mar-06-26	Downgrade	Barclays	Equal Weight → Underweight	$1.50
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31

Show Previous Ratings

Oct-06-26 11:51AM	PacBio Sinks 8% as TychoBio Endorses Its Highest Quality Biological Data the Real Story Is More Complicated (TIKR) -5.92%
09:05AM	PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics (GlobeNewswire)
Oct-01-26 11:44AM	3 Biotech Stocks Put Traders Are Targeting Today (Schaeffer's Research) +5.91%
Sep-03-26 04:05PM	PacBio to Participate in the Morgan Stanley 24?? Annual Global Healthcare Conference (GlobeNewswire)
Aug-05-26 04:46PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press) -9.72% -10.38%
04:08PM	Loading…
04:08PM	PacBio Appoints Mark Van Oene as President and Chief Executive Officer (GlobeNewswire)
04:05PM	PacBio Announces Second Quarter 2026 Financial Results (GlobeNewswire)
09:05AM	PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system (GlobeNewswire)
Jul-28-26 04:05PM	PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-15-26 04:05PM	PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire)
Jun-15-26 02:48PM	Cathie Wood Buys $444 Million in SpaceX, Dumps Tesla and AMD (GuruFocus.com)
May-26-26 09:05AM	PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing (GlobeNewswire)
May-21-26 04:05PM	PacBio to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) +5.04%
May-19-26 09:00AM	Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology (Business Wire)
May-11-26 09:05AM	HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss (GlobeNewswire)
08:30AM	Loading…
May-08-26 08:30AM	Pacific Biosciences of California, Inc. Q1 2026 Earnings Call Summary (Moby) -14.55%
May-07-26 04:33PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press)
04:05PM	PacBio Announces First Quarter 2026 Financial Results (GlobeNewswire)
Apr-21-26 09:05AM	PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing (GlobeNewswire)
Apr-16-26 04:05PM	PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 (GlobeNewswire)
Apr-15-26 09:05AM	PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples (GlobeNewswire)
Mar-18-26 09:05AM	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative (GlobeNewswire)
Mar-06-26 02:00PM	PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know (StockStory) -9.21%
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
08:30AM	PacBio Announces the Appointment of Chris Gibson to the Board of Directors (GlobeNewswire)
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 10:33PM	Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) (StockStory) -6.17%
10:15AM	Loading…
10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-27-26 04:15PM	PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know (StockStory) -5.62%
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-24-26 03:10PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +5.06%
09:05AM	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research (GlobeNewswire)
Feb-20-26 10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
Feb-19-26 11:01PM	PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
12:35AM	5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call (StockStory)
Feb-18-26 04:05PM	PacBio to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:30AM	Pacific Biosciences of California, Inc. Q4 2025 Earnings Call Summary (Moby)
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory)
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory)
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

CEOMr. Mark Van Oene Ph.D.

CFO & Principal Accounting OfficerMr. James R. Gibson II

Senior Business Advisor & DirectorMr. Christian O. Henry M.B.A.

Co-FounderDr. Stephen Turner Ph.D.

Ph.D.Dr. Brett Atkins J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jim Gibson	Officer	Oct 06 '26	Proposed Sale	2.87	661,815	1,899,409		Oct 06 04:23 PM
Van Oene Mark	See Remarks	Aug 17 '26	Sale	1.13	26,911	30,409	2,705,853	Aug 18 08:17 PM
MARK VAN OENE	Officer	Aug 17 '26	Proposed Sale	1.13	26,911	30,512		Aug 17 04:08 PM
Gibson James R II	See Remarks	Apr 01 '26	Sale	1.37	88,185	120,813	1,245,663	Apr 03 04:05 PM
JAMES GIBSON	Officer	Apr 01 '26	Proposed Sale	1.37	88,185	120,778		Apr 01 05:17 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	1.51	12,497	18,920	3,581,813	Mar 04 05:55 PM
Van Oene Mark	See Remarks	Mar 03 '26	Sale	1.51	6,504	9,847	2,243,634	Mar 04 05:54 PM
Farmer Michele	See Remarks	Mar 03 '26	Sale	1.51	2,979	4,510	305,948	Mar 04 05:54 PM
MARK D. VAN OENE	Officer	Mar 03 '26	Proposed Sale	1.51	6,504	9,849		Mar 03 04:24 PM
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	1.51	12,497	18,924		Mar 03 04:20 PM
Van Oene Mark	See Remarks	Feb 17 '26	Sale	1.58	129,790	204,549	1,797,745	Feb 19 08:33 PM
Van Oene Mark	See Remarks	Feb 18 '26	Sale	1.63	55,107	89,769	1,742,638	Feb 19 08:33 PM
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	1.58	331,793	522,906	2,814,374	Feb 19 08:31 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '26	Sale	1.63	140,874	229,484	2,673,500	Feb 19 08:31 PM
Farmer Michele	See Remarks	Feb 17 '26	Sale	1.58	35,215	55,499	234,044	Feb 19 08:28 PM
Farmer Michele	See Remarks	Feb 18 '26	Sale	1.63	14,952	24,357	219,092	Feb 19 08:28 PM
MARK VAN OENE	Officer	Feb 17 '26	Proposed Sale	1.58	303,739	478,693		Feb 17 06:27 PM
CHRISTIAN HENRY	Officer	Feb 17 '26	Proposed Sale	1.58	606,312	955,548		Feb 17 06:25 PM

Open in Screener

MRNA

Moderna Inc

183.79

Oct 07 • 8:00 AM ET -3.67 (-1.96%)

Healthcare Biotechnology USA Large NASD

Peers: BNTX ALNY INCY REGN ARGX BMRN VRTX BIIB AMGN GILD

| Held by: VTI VOO VB IVV SPY VBR IBB XLV CGGR IWR

Index	S&P 500
Market Cap	73.37B
Enterprise Value	69.52B
Income	-3.15B
Sales	2.23B
Book/sh	16.94
Cash/sh	12.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4700
IPO	Dec 07, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	32.93
P/B	10.85
P/C	14.28
P/FCF	-
EV/EBITDA	-
EV/Sales	31.20
Quick Ratio	2.18
Current Ratio	2.29
Debt/Eq	0.19
LT Debt/Eq	0.18
Option/Short	Yes / Yes

EPS (ttm)	-7.98
EPS next Y	-4.75
EPS next Q	-1.10
EPS this Y	-14.57%
EPS next Y	42.91%
EPS next 5Y	27.96%
EPS past 3/5Y	- -29.93%
Sales past 3/5Y	-53.32% 19.33%
EPS Y/Y TTM	-6.22%
Sales Y/Y TTM	-27.62%
EPS Q/Q	7.60%
Sales Q/Q	2.11%
Earnings	Jul 31 BMO
EPS/Sales Surpr.	3.06% 40.87%

Insider Own	8.47%
Insider Trans	-2.30%
Inst Own	79.93%
Inst Trans	2.13%
ROA	-27.43%
ROE	-39.00%
ROIC	-39.41%
Gross Margin	12.57%
Oper. Margin	-149.01%
Profit Margin	-141.43%
SMA20	4.82%
SMA50	39.43%
SMA200	159.58%
Trades

Shs Outstand	399.00M
Shs Float	365.41M
Short Float	9.00%
Short Ratio	1.91
Short Interest	32.87M
52W High	212.22 -13.40%
52W Low	22.28 724.90%
Volatility	8.96% 7.52%
ATR (14)	13.76
RSI (14)	58.29
Beta	1.18
Rel Volume	0.24
Avg Volume	17.18M
Volume	210,294

Perf Week	-4.56%
Perf Month	30.97%
Perf Quarter	140.06%
Perf Half Y	252.76%
Perf YTD	523.22%
Perf Year	572.23%
Perf 3Y	76.92%
Perf 5Y	-40.59%
Perf 10Y	-
Recom	2.89
Target Price	116.84
Prev Close	187.46
Price	183.79
Change %	-1.96%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-26	Downgrade	Citigroup	Neutral → Sell	$80
Sep-03-26	Downgrade	Rothschild & Co Redburn	Neutral → Sell	$81
Aug-28-26	Upgrade	Argus	Hold → Buy	$180
Aug-25-26	Upgrade	Wolfe Research	Underperform → Peer Perform
Aug-19-26	Upgrade	William Blair	Mkt Perform → Outperform
Aug-19-26	Upgrade	BofA Securities	Underperform → Neutral
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70

Show Previous Ratings

Today 06:26AM	Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility (InvestorsHub)
Oct-06-26 05:04PM	Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare. (Barrons.com) -7.75%
04:48PM	Novavax, Moderna stocks fall after WHO calls plague risk 'low' (Yahoo Finance)
11:41AM	Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers (Investor's Business Daily)
Oct-05-26 11:34PM	NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards' (Stocktwits) +6.95%
07:42PM	Loading…
07:42PM	NVAX Stock Outruns Moderna As Vaxcytes Shot Clears A Late-Stage Test (Stocktwits)
03:30PM	MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns (Stocktwits)
12:01AM	Grail Jumps as Cancer Test Nears Market (The Daily Upside)
Oct-03-26 02:31PM	Merck Stock Is Up 61% in a Year. Is There Room Left to Run? (TIKR)
Oct-02-26 06:43AM	Warner Bros. Stock Is About to Leave the Nasdaq. Here's What's Replacing It. (Barrons.com)
05:51AM	Nike, ON Semi, Moderna, and More Stocks That Explain Today's Market (Barrons.com)
04:31AM	Nasdaq, S&P 500, Dow Futures Rise Ahead Of Jobs Report: NKE, META, RKLB, MRNA, SLS, TSLA Stocks In Focus (Stocktwits)
03:02AM	SLS, IBRX Stocks Climb Overnight: Retail Eyes Modernas Rally As MRNA Lands A Nasdaq-100 Spot (Stocktwits)
Oct-01-26 12:21PM	After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move (Investor's Business Daily)
08:03AM	Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz (Investor's Business Daily)
03:18AM	Loading…
03:18AM	Everpure Stock Is Septembers Surprise S&P 500 Winner, Surging More Than 40% As Retail Piles In (Stocktwits)
Sep-30-26 05:09PM	Moderna, Cerebras, Jabil, HPE, Cal-Maine, Mattel, and More Stocks That Explain Today's Market (Barrons.com) -5.35%
04:12PM	After Moderna's Dizzying Rally, It's Time To Sell, Says Analyst (Investor's Business Daily)
03:31PM	Moderna Stock Slumps as Citi Says Its Time to Sell After 500% Rally This Year (Investopedia)
11:28AM	Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter (Barrons.com)
10:59AM	Citi tells investors it's time to sell Moderna after 600%-plus stock gains (MarketWatch)
10:49AM	Moderna Shares Tumble After Citi Delivers Stark Sell Rating (GuruFocus.com)
09:41AM	Tech leads stocks higher after cooler-than-expected inflation read: AlphaCheck (Yahoo Finance)
09:40AM	Target upgraded, Moderna downgraded: Wall Street's top analyst calls (The Fly)
08:03AM	MRNA Stock Falls Premarket After Citi Downgrade: Analyst Says Valuation Looks Stretched Despite Cancer Vaccine Momentum (Stocktwits)
08:02AM	Premarket movers: Micron; Boeing rises, Moderna slides (Investing.com)
07:42AM	Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded It to Sell. (Barrons.com)
07:00AM	Moderna Adds Chief Operating Officer Role as Company Expands into Oncology (ACCESSWIRE)
Sep-28-26 06:29AM	Intel's stock drops as AI fears mount, and other early market movers (MarketWatch)
03:59AM	MRNA Stock Eyes Best Year Ever: Analyst Calls Chinas AI Drug Lead Baseless As Moderna Awaits Cancer Data (Stocktwits)
03:37AM	Loading…
03:37AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to fall after Trump rejects Iran offer; Oil climbs, Treasury yields jump; Nvidia stock rises (MarketWatch)
12:47AM	Why Did AMD, HPE, MRNA Stocks Surge To 52-Week Highs Last Week? (Stocktwits)
Sep-27-26 08:46AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
Sep-25-26 02:37PM	MRNA, PGEN Stocks Hit Multi-Year Highs Whats Driving The Momentum Today? (Stocktwits)
11:39AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
01:07AM	Moderna Stock Jumped 7% Thursday. The Real Test Comes at ESMO on October 24. (TIKR)
Sep-24-26 11:23PM	MRNA On Track To Be September's No. 2 S&P 500 Stock But These 5 Smaller Health Care Names Did Even Better (Stocktwits) +6.98%
06:41PM	From $63 To $195: Modernas Two-Month Rerating Isnt Done (Stocktwits)
Sep-23-26 11:52PM	Why Did META, MRNA, OKTA Stocks Surge To 52-Week Highs Today? (Stocktwits)
01:54PM	These 2 Stocks Are Bucking The Broader Market Selloff To Hit New Multi-Year Highs Heres Whats Driving The Enthusiasm (Stocktwits)
12:53PM	Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker Is Going Next (Barrons.com)
08:28AM	6 'Moonshot' Biotech Stocks That Offer Big Risks, Bigger Rewards (Barrons.com)
01:45AM	These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right. (Barrons.com)
Sep-22-26 01:39PM	Was Moderna Stock's Cancer Vaccine Run Visible In Advance? (Trefis) +5.56%
03:33AM	Moderna Stock Jumped 12% Yesterday. An ESMO Presidential Slot Explains Why. (TIKR)
Sep-21-26 11:39PM	Why Did AMD, WBD, MRNA Stocks Surge To 52-Week Highs Today? (Stocktwits) +12.27%
03:43PM	Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters. (MarketWatch)
01:40PM	Moderna To Present Additional Data From Key Melanoma Trial At ESMO Congress Retail Says Breakout Is Getting Hard To Ignore (Stocktwits)
01:12PM	Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test. (Barrons.com)
10:12AM	Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026 (ACCESSWIRE)
03:00AM	Modernas Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinsons drug (Fortune)
Sep-20-26 05:14PM	3 Bullish Setups for the Week Ahead (Zacks)
Sep-18-26 08:27AM	One stock is up 540%, and it's not alone (GuruFocus.com)
08:03AM	Dow Jones Futures: After S&P 500, Nasdaq Rebound, What's Next? Moderna, AMD, SpaceX Flash Buy Signals. (Investor's Business Daily)
Sep-17-26 03:52PM	Will 2026 Doom and Gloom Lead to Opportunity? (Zacks) +8.55%
12:32PM	Moderna: Another Day, Another Big Stock Move. Is the Cancer Vaccine Rally Back On? (Barrons.com)
03:21AM	This Tiny Biotech Is Beating MRNA, IOVA And SLS Here's How A Billionaire Fueled Its September Rally (Stocktwits)
Sep-14-26 10:00AM	AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033 (PR Newswire)
Sep-13-26 04:34PM	Dow Jones Futures: Will Anthropic-Led Call For Slowdown Hit AI Stocks? Fed Meeting Aheadan, SpaceX's Musk Call For AI Slowdown (Investor's Business Daily)
Sep-11-26 04:40PM	How Cathie Wood's Fund Gave Us A Back Door To Moderna's Breakthrough (Investor's Business Daily) +5.38%
Sep-10-26 05:17AM	mRNA cancer vaccines biggest barriers to market (Pharma Voice)
Sep-08-26 04:50PM	AI, Cancer Vaccines, and Next-Gen Medicine (Zacks)
Sep-07-26 09:49PM	The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI (BeInCrypto)
Sep-04-26 06:10AM	GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says (Proactive)
Sep-03-26 01:39PM	Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense (Barrons.com)
11:10AM	Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating (Barrons.com)
09:31AM	Broadcom upgraded, Ultragenyx downgraded: Wall Street's top analyst calls (The Fly)
Sep-02-26 02:45PM	15 Stocks to Watch With Short Squeeze Potential (Schaeffer's Research)
12:02AM	Biotech Is Popping. No One Seems to Care. (The Daily Upside)
Sep-01-26 11:12AM	GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial (Clinical Trials Arena) +9.93%
08:40AM	Enterprise software led August's rebound as AI fears faded, Cramer says (Quartz)
08:37AM	S&P 500 biggest August 2026 winners: Moderna, software stocks (Quartz)
07:00AM	Moderna to Present at Upcoming Conferences in September 2026 (ACCESSWIRE)
Aug-31-26 02:20PM	These ETFs capture some of the biggest market moves in August (MarketWatch)
12:50PM	Moderna Led the S&P 500 in August as Edison International Sank (Barrons.com)
12:22PM	22 best-performing stocks of August, as the software industry continues its recovery (MarketWatch)
11:59AM	Six stocks are on pace for their best month on record (MarketWatch)
Aug-28-26 01:22PM	BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt BMO Capital Terms It Clear Setback (Stocktwits)
10:46AM	BioNTech Stock Falls on Cancer Vaccine Setback (Barrons.com)
10:09AM	BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast (Investing.com)
09:38AM	Moderna upgraded, Allstate downgraded: Wall Street's top analyst calls (The Fly)
07:59AM	Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines (BioPharma Dive)
07:00AM	Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes (ACCESSWIRE)
Aug-27-26 03:56PM	Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines (ACCESSWIRE)
09:26AM	Modernas $2B Convertible-Note Deal To Focus On Oncology Growth, Debt Repayment But Retail Calls It A Bull Trap (Stocktwits)
08:30AM	Moderna is raising $2 billion in convertible debt to fund its cancer drug push (Quartz)
08:20AM	Moderna raises $2 billion in convertible notes for cancer vaccine (Quartz)
07:20AM	Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes (ACCESSWIRE)
03:09AM	SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Woods ARK Backs Personalized Cancer-Vaccine Future (Stocktwits)
Aug-26-26 02:48PM	Novavax Stock Pulls Back After Milestone Vaccine Success (Schaeffer's Research) -5.77%
01:49PM	Energy, Industrials, and Utilities Are Leading the Stock Market (Barrons.com)
11:13AM	Moderna Stock Carries A Market Value Its Revenue Does Not Support (Trefis)
08:00AM	Binance offering perpetual contracts with 20x leverage: How not to invest? (Yahoo Finance Video)
Aug-25-26 07:55PM	Review & Preview: Risky Business (Barrons.com) +14.36%
06:43PM	MRNA Stock Jumps 14% Past $150 As Wolfe Sees $9.2B Cancer-Vaccine Opportunity (Stocktwits)
05:22PM	KURA Stock Hits Fresh 52-Week High As CEO Buys More Shares Retail Wonders If Wilson Is Following Moderna CEOs Playbook (Stocktwits)
01:46PM	Moderna's Cancer Vaccine Gives Stock a New Growth Story. Will It Have a Happy Ending? (Barrons.com)
01:17PM	Moderna Stock Soars on Cancer Vaccine Breakthrough (GuruFocus.com)
11:54AM	3 Reasons AI Stocks are Primed for a Rebound (Zacks)
10:37AM	What Happens if Moderna's Cancer Vaccine Works (Barrons.com)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

CEO & DirectorMr. Stephane Bancel M.B.A.

PresidentDr. Stephen Hoge M.D.

Chief Financial OfficerMr. James M. Mock

Chief Legal Officer & Corporate SecretaryMs. Shannon Thyme Klinger J.D.

Chief Technical Operations & Quality OfficerDr. Jerh Collins Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoge Stephen	President	Sep 14 '26	Option Exercise	12.21	76,453	933,491	1,566,152	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Option Exercise	12.21	76,452	933,479	1,602,310	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Sale	146.07	40,281	5,883,846	1,562,029	Sep 16 04:48 PM
Hoge Stephen	President	Sep 14 '26	Sale	144.13	40,294	5,807,574	1,525,858	Sep 16 04:48 PM
Hoge Stephen	Officer	Sep 15 '26	Proposed Sale	146.07	40,281	5,883,709		Sep 15 10:46 AM
Mock James M	Chief Financial Officer	Sep 10 '26	Option Exercise	30.96	19,836	614,123	94,211	Sep 14 04:25 PM
Mock James M	Chief Financial Officer	Sep 10 '26	Sale	134.49	34,836	4,685,094	59,375	Sep 14 04:25 PM
Hoge Stephen	Officer	Sep 14 '26	Proposed Sale	144.13	40,294	5,807,746		Sep 14 02:39 PM
Mock James M	Officer	Sep 10 '26	Proposed Sale	134.49	34,836	4,685,094		Sep 10 10:14 AM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Option Exercise	30.96	3,471	107,462	77,600	Sep 03 04:56 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Sale	139.95	3,471	485,766	74,129	Sep 03 04:56 PM
Klinger Shannon Thyme	Officer	Sep 01 '26	Proposed Sale	139.95	3,471	485,766		Sep 01 11:22 AM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Option Exercise	19.15	499,246	9,560,561	6,687,037	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 06 '26	Option Exercise	19.15	252,469	4,834,781	6,440,260	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Sale	57.52	499,246	28,715,011	6,187,791	Aug 07 04:11 PM
Bancel Stephane	Officer	Aug 05 '26	Proposed Sale	58.00	499,246	28,956,268		Aug 05 01:02 PM
Hoge Stephen	President	Jul 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jul 16 04:45 PM
Hoge Stephen	President	Jul 15 '26	Sale	67.60	53,336	3,605,514	1,483,848	Jul 16 04:45 PM
Hoge Stephen	Officer	Jul 15 '26	Proposed Sale	67.60	53,336	3,605,514		Jul 15 10:22 AM
SAGAN PAUL	Former Director	Jun 18 '26	Proposed Sale	64.57	25,770	1,663,875		Jun 18 03:26 PM
Hoge Stephen	President	Jun 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jun 17 04:10 PM
Hoge Stephen	President	Jun 15 '26	Sale	51.37	53,336	2,739,870	1,483,848	Jun 17 04:10 PM
Hoge Stephen	Officer	Jun 15 '26	Proposed Sale	51.37	53,336	2,739,870		Jun 15 11:43 AM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Option Exercise	30.96	3,471	107,462	70,939	Jun 08 04:34 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Sale	50.00	3,471	173,550	67,468	Jun 08 04:34 PM
Klinger Shannon Thyme	Officer	Jun 04 '26	Proposed Sale	50.00	3,471	173,550		Jun 04 01:26 PM
AFEYAN NOUBAR	Director	May 21 '26	Option Exercise	19.15	9,263	177,386	13,187	May 22 07:00 PM
AFEYAN NOUBAR	Director	May 21 '26	Sale	46.84	9,263	433,879	3,924	May 22 07:00 PM
Flagship Pioneering, LLC	Affiliate	May 21 '26	Proposed Sale	46.84	9,263	433,880		May 21 03:06 PM
Hoge Stephen	President	May 15 '26	Option Exercise	19.15	53,336	1,021,384	1,531,333	May 18 04:57 PM
Hoge Stephen	President	May 15 '26	Sale	48.40	53,336	2,581,462	1,477,997	May 18 04:57 PM
Hoge Stephen	Officer	May 15 '26	Proposed Sale	48.40	53,336	2,581,462		May 15 09:47 AM
SAGAN PAUL	Former Director	May 08 '26	Proposed Sale	54.48	36,759	2,002,787		May 08 11:24 AM
Hussain Abbas	Director	May 01 '26	Sale	46.63	5,682	264,952	12,066	May 04 05:25 PM
Hussain Abbas	Director	May 01 '26	Proposed Sale	46.63	5,682	264,952		May 01 11:44 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Option Exercise	30.96	13,885	429,880	73,574	Mar 03 04:10 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Sale	52.29	13,885	726,047	59,689	Mar 03 04:10 PM
Klinger Shannon Thyme	Officer	Mar 02 '26	Proposed Sale	52.29	13,885	726,047		Mar 02 09:56 AM
Hoge Stephen	President	Feb 23 '26	Option Exercise	19.15	160,009	3,064,172	1,617,436	Feb 25 04:49 PM
Hoge Stephen	President	Feb 23 '26	Sale	48.84	160,009	7,814,840	1,457,427	Feb 25 04:49 PM
Hoge Stephen	Officer	Feb 23 '26	Proposed Sale	48.84	160,009	7,814,840		Feb 23 10:26 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your Finviz experience